Daiichi Sankyo Co., Ltd. Share Price

Equities

4568

JP3475350009

Pharmaceuticals

Market Closed - Japan Exchange 07:00:00 29/05/2024 BST 5-day change 1st Jan Change
5,452 JPY -0.78% Intraday chart for Daiichi Sankyo Co., Ltd. -0.80% +40.81%

Financials

Sales 2024 1,602B 10.19B 799B Sales 2025 * 1,772B 11.27B 884B Capitalization 10,534B 66.98B 5,253B
Net income 2024 201B 1.28B 100B Net income 2025 * 197B 1.25B 98.08B EV / Sales 2024 5.72 x
Net cash position 2024 * 556B 3.53B 277B Net cash position 2025 * 684B 4.35B 341B EV / Sales 2025 * 5.56 x
P/E ratio 2024
45.6 x
P/E ratio 2025 *
53.4 x
Employees 17,435
Yield 2024
1.05%
Yield 2025 *
1.09%
Free-Float 97.04%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.78%
1 week+0.48%
Current month+1.64%
1 month+1.64%
3 months+9.61%
6 months+38.66%
Current year+40.81%
More quotes
1 week
5 266.00
Extreme 5266
5 656.00
1 month
5 194.00
Extreme 5194
5 656.00
Current year
3 847.00
Extreme 3847
5 656.00
1 year
3 566.00
Extreme 3566
5 656.00
3 years
1 981.00
Extreme 1981
5 656.00
5 years
1 731.00
Extreme 1731
5 656.00
10 years
518.67
Extreme 518.6667
5 656.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 69 31/03/07
President 61 31/03/17
Chief Tech/Sci/R&D Officer - 31/03/21
Members of the board TitleAgeSince
Director/Board Member 66 31/05/19
Director/Board Member 75 31/05/19
Chief Executive Officer 69 31/03/07
More insiders
Date Price Change Volume
29/05/24 5,452 -0.78% 3,633,300
28/05/24 5,495 -2.35% 4,289,300
27/05/24 5,627 +3.36% 3,000,200
24/05/24 5,444 +1.25% 3,453,900
23/05/24 5,377 -0.90% 3,412,900

Delayed Quote Japan Exchange, May 29, 2024 at 07:00 am

More quotes
Daiichi Sankyo Company specializes in developing, manufacturing and marketing pharmaceutical products. Net sales break down by activity as follows: - sale of medicines (99.8%): prescription medicines (92.8% of net sales) and OTC medicines (7.2%) primarily for the treatment of thrombotic disorders, tumors, diabetes and rheumatoid arthritis; - other (0.2%): primarily real estate activities. Net sales are distributed geographically as follows: Japan (64.1%), North America (17.2%), Europe (9.7%) and other (9%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,495 JPY
Average target price
5,977 JPY
Spread / Average Target
+8.77%
Consensus